This website provides educational information about medicines and active ingredients. It does not replace medical advice, diagnosis or treatment from a qualified healthcare professional.
Pharmacists

Veletri 0.5 mg Powder for Infusion: Uses and Safety

Quick summary Veletri 0.5 mg contains epoprostenol sodium and is used as a continuous intravenous infusion for pulmonary arterial hypertension (PAH). Because it is a specialist treatment, dosing, preparation, and monitoring must follow the...

Educational content Use this article as a starting point for understanding the topic.
Check with a professional Ask a doctor or pharmacist before changing any medicine.
Safety first Side effects, interactions and risks depend on each person.
Medical disclaimer

This content is for educational purposes only and does not replace medical advice, diagnosis or treatment from a qualified healthcare professional.

Quick summary

Veletri 0.5 mg contains epoprostenol sodium and is used as a continuous intravenous infusion for pulmonary arterial hypertension (PAH). Because it is a specialist treatment, dosing, preparation, and monitoring must follow the prescriber’s instructions and the official product information.

Medical disclaimer

This article is for general information only and does not replace advice from a doctor, pharmacist, or the official patient leaflet. Do not use it to diagnose a condition or to change any treatment plan.

What is Veletri 0.5 mg?

Veletri 0.5 mg is a powder for solution for infusion that contains epoprostenol sodium. It is used in the management of pulmonary arterial hypertension (PAH), a serious condition that affects blood flow in the lungs.

As described in the original content, epoprostenol acts as a vasodilator, helping relax blood vessels and reduce pressure in the pulmonary artery. It is a prescription medicine used under close medical supervision.

How is Veletri given?

Veletri is administered by continuous intravenous infusion. This means the medicine is delivered steadily into a vein rather than given as a one-off dose.

The original content notes that treatment is usually started at 2 ng/kg/min, with later adjustments based on response and tolerance. Any changes to the infusion rate should be made by a healthcare professional.

Why is monitoring important?

Continuous infusion medicines need careful handling. Patients may need specialist equipment, training, and regular review to make sure the infusion is running correctly.

Monitoring is important because the medicine’s effect depends on a stable infusion and because side effects or complications may need prompt attention.

What is Veletri used for?

Based on the original content, Veletri is primarily used for pulmonary arterial hypertension (PAH). It may be part of a wider treatment plan for people with severe symptoms that affect daily life.

  • PAH may cause shortness of breath.
  • Fatigue and chest pain may also occur.
  • The treatment aim is to support exercise capacity and quality of life.

The original text also mentions use in urgent situations such as during renal dialysis. If this applies, the exact reason for use should be confirmed with the treating team.

What should patients and carers check before use?

Before treatment, it is sensible to confirm the following with the prescriber or pharmacist:

  • How the infusion is prepared and administered
  • What monitoring is needed
  • What to do if the infusion is interrupted
  • Which symptoms should be reported urgently
  • How to store and handle the medicine and equipment

These details should always come from the official product information or the clinical team responsible for care.

Possible side effects mentioned in the original content

Like all medicines, Veletri can cause side effects. The original content lists the following:

  • Nausea and vomiting
  • Flushing and headache
  • Low blood pressure (hypotension)

It also notes that more serious problems such as bleeding or arrhythmias may occur and require close monitoring.

Precautions and safety points

The original content highlights several precautions. Patients should tell their healthcare team about any relevant medical history, including:

  • Heart disease or arrhythmias
  • Liver or kidney impairment
  • Pregnancy or breastfeeding status

It also stresses that abrupt changes in dosage should be avoided. Because this is a continuous infusion treatment, any interruption or adjustment should be handled by a clinician.

What to verify in the official leaflet

If you are checking this medicine for professional or patient information purposes, the official leaflet and product label should be reviewed for:

  • Preparation and reconstitution instructions
  • Infusion setup and administration steps
  • Storage requirements
  • Warnings and monitoring advice
  • Full side effect and interaction information

This is especially important because infusion medicines can differ by presentation and handling requirements.

At a glance

Item Information from the source content
Active ingredient Epoprostenol sodium
Dosage form Powder for solution for infusion
Route Continuous intravenous infusion
Main use Pulmonary arterial hypertension (PAH)
Starting infusion rate mentioned 2 ng/kg/min

Frequently asked questions

▸ What is the infusion rate for Veletri?

The original content states that treatment typically starts at 2 ng/kg/min. The rate may then be adjusted by a healthcare professional based on response and tolerance.

▸ Can Veletri be given intravenously?

Yes. Veletri is described as a medicine for continuous intravenous infusion.

▸ What condition is Veletri used for?

The source content says it is primarily used for pulmonary arterial hypertension (PAH).

▸ What side effects are mentioned?

The original text mentions nausea, vomiting, flushing, headache, low blood pressure, bleeding, and arrhythmias.

▸ How should reconstitution be checked?

The original content says reconstitution should follow the manufacturer’s instructions. The official leaflet or product label should be used for exact preparation steps.

Safety reminder

Because Veletri is given by continuous infusion, any problem with the pump, line, preparation, or infusion rate should be reviewed promptly by the treating healthcare team. Do not rely on general information alone for administration decisions.

Editorial note Active Ingredients Online Editorial Team This article is prepared as educational medicine information for general readers. It is written to support understanding of active ingredients, medicine uses, possible side effects, precautions and safety-related questions.
Published: December 20, 2024 Updated: June 5, 2026 Educational content

Medical disclaimer

This content is for educational purposes only. It should not be used as a substitute for professional medical advice, diagnosis or treatment. Always ask a doctor, pharmacist or qualified healthcare professional before starting, stopping or changing any medicine.

Sources and verification

The following sources or official references are listed to support verification of the medicine information discussed in this article.

Final note

Medicine information can change and may vary depending on country, product formulation, patient history and professional guidance. Always check official medicine information and ask a healthcare professional for personal medical questions.

See also...
Ask a Doctor Online medical questions